MSB 1.03% 98.0¢ mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-3

  1. 1,787 Posts.
    lightbulb Created with Sketch. 315
    “Moreover, in the observational cohort study 88% of children treated with remestemcel-L had severe disease with highest mortality risk, defined by either IBMTR Grade C/D or Glucksberg Grade III/IV, whereas only 22% to 68% of patients in the other studies were considered to be severe.“
    MSB - taking on the worst of the worst - and succeeding.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
98.0¢
Change
0.010(1.03%)
Mkt cap ! $1.118B
Open High Low Value Volume
96.0¢ 99.0¢ 95.5¢ $5.286M 5.409M

Buyers (Bids)

No. Vol. Price($)
3 91218 98.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 63577 4
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.